A carregar...
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion
Among the various types of breast cancer, the luminal B subtype is the most common in young women, and ESR1-CCDC170 (E:C) fusion is the most frequent oncogenic fusion driver of the luminal B subtype. Nevertheless, treatments targeting E:C fusion has not been well established yet. Hence, the aim of t...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7913953/ https://ncbi.nlm.nih.gov/pubmed/33557149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040582 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|